Home Cart Sign in  
Chemical Structure| 28978-02-1 Chemical Structure| 28978-02-1

Structure of Pectolinarin
CAS No.: 28978-02-1

Chemical Structure| 28978-02-1

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Pectolinarigenin, a natural product isolated and purified from the herbs of Cirsium japonicum DC., possesses hepatoprotective and anti-inflammatory activity.

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Pectolinarin

CAS No. :28978-02-1
Formula : C29H34O15
M.W : 622.57
SMILES Code : O=C1C=C(C2=CC=C(OC)C=C2)OC3=CC(O[C@H]4[C@@H]([C@H]([C@@H]([C@@H](CO[C@H]5[C@@H]([C@@H]([C@H]([C@H](C)O5)O)O)O)O4)O)O)O)=C(OC)C(O)=C13
MDL No. :MFCD12407436

Safety of Pectolinarin

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319-H335
Precautionary Statements:P261-P305+P351+P338

Related Pathways of Pectolinarin

GPCR
pyroptosis

Isoform Comparison

Biological Activity

In Vitro:

Cell Line
Concentration Treated Time Description References
Staphylococcus aureus 0.39 μg/mL (IC50) 24 hours Inhibited biofilm formation Antibiotics (Basel). 2022 Apr 29;11(5):598
Streptococcus sobrinus 1.4 μg/mL (IC50) 24 hours Inhibited biofilm formation Antibiotics (Basel). 2022 Apr 29;11(5):598
Streptococcus mutans 1.2 μg/mL (IC50) 24 hours Inhibited biofilm formation Antibiotics (Basel). 2022 Apr 29;11(5):598
Escherichia coli 0.25 μg/mL (IC50) 24 hours Inhibited biofilm formation Antibiotics (Basel). 2022 Apr 29;11(5):598
Enterococcus faecium 0.19 μg/mL (IC50) 24 hours Inhibited biofilm formation Antibiotics (Basel). 2022 Apr 29;11(5):598
Enterococcus faecalis 0.39 μg/mL (IC50) 24 hours Inhibited biofilm formation Antibiotics (Basel). 2022 Apr 29;11(5):598
T24 cells 0.01–50 μg/mL 24 hours Reduced bacterial adherence Antibiotics (Basel). 2022 Apr 29;11(5):598
Porphyromonas gingivalis 9.0 μg/mL (IC50) 24 hours Inhibited biofilm formation Antibiotics (Basel). 2022 Apr 29;11(5):598
Cutibacterium acnes 12.5 μg/mL (IC50) 24 hours Inhibited biofilm formation Antibiotics (Basel). 2022 Apr 29;11(5):598
Pseudomonas aeruginosa 0.9 μg/mL (IC50) 24 hours Inhibited biofilm formation Antibiotics (Basel). 2022 Apr 29;11(5):598
SARS-CoV 3CLpro 37.78 µM 16 hours Inhibition of SARS-CoV 3CLpro enzymatic activity J Enzyme Inhib Med Chem. 2020 Dec;35(1):145-151
L-929 fibroblasts 20 μg/mL 2 hours Evaluate the antioxidant capacity of Pectolinarin, results showed that 20 μg/mL of Pectolinarin effectively counteracted the detrimental effects of reactive oxygen species (ROS). J Cell Mol Med. 2024 Feb;28(4):e18130
SH-SY5Y neuronal cells 1, 2.5, 5, 10 µg/mL 24 hours To investigate the protective effects of Pectolinarin against H2O2-induced oxidative stress. Results showed that Pectolinarin significantly increased cell viability and reduced ROS production and LDH release. Molecules. 2023 Aug 2;28(15):5826
EA.hy926 endothelial cells 25, 50, 100, 200 μg/mL 24, 48, 72 hours Assess the effect of Pectolinarin on endothelial cell proliferation, results showed that 50 μg/mL of Pectolinarin significantly promoted endothelial cell proliferation. J Cell Mol Med. 2024 Feb;28(4):e18130

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
C57BL/6 female mice Ovariectomy model Oral 20 mg/kg Once daily for 8 weeks To evaluate the protective effects of Pectolinarin on ovariectomy-induced osteoporosis, results showed Pectolinarin inhibited bone resorption and promoted bone formation. Int J Mol Sci. 2023 Jan 13;24(2):1620
Mice LPS-induced acute liver and kidney injury model Intraperitoneal injection 25 mg/kg and 50 mg/kg Once daily for 3 days To evaluate the protective effect of Pectolinarin on LPS-induced acute liver and kidney injury. Results showed that Pectolinarin significantly alleviated histopathological injuries in liver and kidney and reduced serum TNF-α levels. Molecules. 2022 Dec 8;27(24):8695
Sprague Dawley (SD) rats Full-thickness skin defect model Topical administration 50 μg/mL Replenished every 3 days for 14 days Evaluate the effect of Pectolinarin hydrogel on wound healing and scar formation, results showed that 50 μg/mL of Pectolinarin hydrogel significantly promoted wound healing and minimized scar formation. J Cell Mol Med. 2024 Feb;28(4):e18130

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

1.61mL

0.32mL

0.16mL

8.03mL

1.61mL

0.80mL

16.06mL

3.21mL

1.61mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1
Protocol 2

References

 

Historical Records

Categories